Navellier & Associates Inc Trinity Biotech PLC Transaction History

Navellier & Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.43 - $2.25 $22,143 - $34,841	-15,485 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$1.82 - $2.94 $154,929 - $250,270	-85,126 Reduced 84.61%	15,485 $33,000
Q2 2021 Aug 09, 2021	BUY	$2.77 - $4.18 $52,256 - $78,855	18,865 Added 23.08%	100,611 $296,000
Q1 2021 May 12, 2021	BUY	$3.26 - $6.64 $54,650 - $111,312	16,764 Added 25.8%	81,746 $307,000
Q4 2020 Feb 05, 2021	BUY	$1.95 - $4.77 $126,714 - $309,964	64,982 New	64,982 $248,000

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $30.1M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.